Who owns IMMUNEERING CORP - CLASS A?
- Ticker: IMRX
- CUSIP Number: 45254e107
Tip: Access positions for across all investors
Analyze quarterly positions in Immuneering Corp - Class A with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Immuneering Corp - Class A stock
Who bought or sold IMMUNEERING CORP - CLASS A this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Vanguard Group | 1.1M | $1.4M | -11% | Jun 2024 |
|
| T. Rowe Price Associates | 810k | $2.0M | -6% | Sep 2024 |
|
| Goldman Sachs Group | 742k | $949k | 63% | Jun 2024 |
|
| BlackRock | 533k | $683k | -61% | Jun 2024 |
|
| BlackRock | 318k | $793k | 100% | Sep 2024 |
|
| Two Sigma Advisers | 249k | $318k | 100% | Jun 2024 |
|
| Two Sigma Investments | 210k | $269k | 100% | Jun 2024 |
|
| Geode Capital Management | 210k | $522k | -5% | Sep 2024 |
|
| TD Asset Management | 151k | $401k | 0% | Sep 2024 |
|
| Manufacturers Life Insurance Company | 83k | $106k | -5% | Jun 2024 |
|
| First Manhattan | 74k | $95k | 123% | Jun 2024 |
|
| State Street Corporation | 69k | $89k | -82% | Jun 2024 |
|
| CI Private Wealth | 64k | $159k | 47% | Sep 2024 |
|
| Exchange Traded Concepts | 58k | $145k | -22% | Sep 2024 |
|
| Bridgeway Capital Management | 54k | $69k | -53% | Jun 2024 |
|
| Tidemark | 52k | $129k | 100% | Sep 2024 |
|
| Morgan Stanley | 46k | $59k | 1% | Jun 2024 |
|
| HighTower Advisors | 44k | $57k | 100% | Jun 2024 |
|
| Northern Trust | 40k | $99k | -77% | Sep 2024 |
|
| Bank of America Corporation | 31k | $78k | -2% | Sep 2024 |
|
| Squarepoint Ops | 24k | $31k | 100% | Jun 2024 |
|
| Pnc Financial Services | 20k | $50k | -1% | Sep 2024 |
|
| Point72 Asia | 18k | $44k | -48% | Sep 2024 |
|
| Man Group | 14k | $34k | 100% | Sep 2024 |
|
| Dimensional Fund Advisors | 13k | $33k | 0% | Sep 2024 |
|
| Tower Research Capital | 12k | $15k | 147% | Jun 2024 |
|
| Royal Bank of Canada | 11k | $38k | 100% | Sep 2024 |
|
| Qube Research & Technologies | 11k | $14k | 100% | Jun 2024 |
|
| Vontobel Holding | 10k | $25k | 100% | Sep 2024 |
|
| Corsair Capital Management | 10k | $25k | 100% | Sep 2024 |
|
| Atlantic Trust | 10k | $25k | 100% | Sep 2024 |
|
| Barclays | 9.9k | $25k | -2% | Sep 2024 |
|
| Russell Investments | 6.6k | $8.4k | 100% | Jun 2024 |
|
| Federated Investors | 5.1k | $13k | 14% | Sep 2024 |
|
| Jpmorgan Chase & Co | 2.4k | $6.0k | 23% | Sep 2024 |
|
| Macquarie Group | 1.1k | $1.5k | 100% | Jun 2024 |
|
| Citigroup | 796.00 | $2.0k | -83% | Sep 2024 |
|
| Cubist Systematic Strategies | 660.00 | $1.6k | -89% | Sep 2024 |
|
| EverSource Wealth Advisors | 345.00 | $859.015500 | 0% | Sep 2024 |
|
| Point72 | 16.00 | $40.000000 | -100% | Sep 2024 |
|
Who sold out of Immuneering Corp - Class A?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Cormorant Asset Management | Mar 2024 | 3.3M | $9.5M |
| Citadel Advisors | Jun 2024 | 1.9M | $2.4M |
| Millennium Management | Jun 2024 | 953k | $1.2M |
| Marshall Wace | Jun 2024 | 384k | $492k |
| Renaissance Technologies | Jun 2024 | 349k | $447k |
| Susquehanna International | Jun 2024 | 89k | $114k |
| Jane Street | Jun 2024 | 75k | $96k |
| Y-Intercept | Jun 2024 | 60k | $77k |
| Acadian Asset Management | Jun 2024 | 53k | $67k |
| Centiva Capital | Jun 2024 | 46k | $59k |
| Nuveen Asset Management | Mar 2024 | 44k | $127k |
| XTX Topco | Jun 2024 | 34k | $44k |
| Hrt Financial | Jun 2024 | 21k | $27k |
| Sunrise Partners Limited Partnership | Jun 2024 | 18k | $23k |
| Ground Swell Capital | Jun 2024 | 12k | $15k |
| Mirae Asset Global Etfs Holdings | Jun 2024 | 11k | $15k |
| Rhumbline Advisers | Jun 2024 | 3.4k | $4.3k |
| Nordwand Advisors | Jun 2024 | 2.0k | $2.6k |
| Advisor Group Holdings | Mar 2024 | 1.0k | $2.9k |
| New York State Common Retirement Fund | Jun 2024 | 209.00 | $0 |
| Farther Finance Advisors | Jun 2024 | 80.00 | $94.000000 |
| Capital Advisors | Jun 2024 | 39.00 | $0 |
| CWM | Jun 2024 | 29.00 | $0 |